Jarvik Heart, Inc. Product Pipeline Analysis

Global Markets Direct, January 2009, Pages: 26

Jarvik Heart, Inc. Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a Scope’s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

- Details of development stage by sector and equipment type.
- Pipeline products grouped by therapy area, development stage and trial phase.
- Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
- Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
- Product updates covering estimated approval dates and estimated launch dates.
- Descriptions of novel technologies relating to pipeline products of the company.
- Patents and patent applications covered for the product.
- News updates on key events relating to the product and its development.

Reasons to buy

- A single source to fulfill competitor information relating to products in development.
- Identify pipeline products that are potential competitor to your product lines.
- Understand a companys strategic position by accessing detailed independent intelligence on its product pipeline.
- Access clinical trial information to map trial results and plan targeted marketing activities.
- Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
- Identification of potential investment opportunities.
- Build up knowledge base for potential distribution and marketing partners.
- Helps avoid patent infringement.
- Timelines from concept to market lets you keep track of market potential build for a new product.
- Assess a companys future growth by determining its pipeline depth, for probable acquisition opportunities.

1 2
1.1 List Of Tables 4
1.2 List of Figures 5
2 Company Overview 6
2.1 Key Information 6
2.2 Industry Outlook - Cardiovascular Devices 6
3 Jarvik Heart, Inc. Pipeline Products 7
3.1 Jarvik Heart, Inc. Product Pipeline Analysis 7
3.1.1 Jarvik Heart, Inc. Pipeline Products By Equipment Type 7
3.1.2 Jarvik Heart, Inc. Pipeline Products By Development Stage 8
3.1.3 Jarvik Heart, Inc. Pipeline Products By Therapy Area 9
3.1.4 Jarvik Heart, Inc. Pipeline Products By Clinical Trials 9
3.1.5 Jarvik Heart, Inc. Pipeline Products By News Summary 10
3.2 Jarvik 2000 FlowMaker 11
3.2.1 Product Status 11
3.2.2 Product Description 11
3.2.3 Product Milestone 12
3.2.4 Jarvik 2000 FlowMakerClinical Trials 1 12
3.2.5 Jarvik 2000 FlowMakerClinical Trials 2 13
3.3 Jarvik 2000 (DT) 13
3.3.1 Product Status 13
3.3.2 Product Description 13
3.3.3 Jarvik 2000 (DT)Clinical Trials 1 14
3.3.4 Jarvik 2000 (DT)Clinical Trials 2 15
3.4 Jarvik 2000 (Wearless) 15
3.4.1 Product Status 15
3.4.2 Product Description 16
3.5 Jarvik (miniaturized version) 16
3.5.1 Product Status 16
3.5.2 Product Description 16
3.5.3 Product Milestone 16
3.6 Jarvik 2000 (BTT) 17
3.6.1 Product Status 17
3.6.2 Product Description 17
3.6.3 Jarvik 2000 (BTT)Clinical Trials 1 18
3.6.4 Jarvik 2000 (BTT)Clinical Trials 2 19
3.6.5 Jarvik 2000 (BTT)Clinical Trials 3 19
3.6.6 Jarvik 2000 (BTT)Clinical Trials 4 20
3.6.7 Product Patent Details 20
4 Recent Developments 21
4.1 Product News 21
4.1.1 Jul 12, 2005: FDA Approves Pivotal Trial Of The Jarvik 2000 FlowMaker 21
4.1.2 May 10, 2005: Jarvik 2000 FlowMaker CE Mark Approved In Europe 21
4.1.3 Apr 27, 2004: Jarvik Heart Awarded Major NIH Contract To Develop Heart Pump For Children 22
4.2 Product Approvals 22
4.2.1 May 10, 2005: Jarvik 2000 FlowMaker CE Mark Approved In Europe 22
4.3 Clinical Trials 22
4.3.1 Jul 12, 2005: FDA Approves Pivotal Trial Of The Jarvik 2000 FlowMaker 22
5 Appendix 24
5.1 Methodology 24
5.1.1 Coverage 24
5.1.2 Secondary Research 25
5.1.3 Primary Research 25
5.1.4 Expert Panel Validation 26
5.2 Contact Us 26
5.3 About us26
5.4 Disclaimer 26

Executive Summary

1.2 List of Figures
Figure 1: Jarvik Heart, Inc. Pipeline Products By Development Stage 8
Figure 2: Jarvik Heart, Inc. Pipeline Products By News Summary 10
Figure 3: Global Markets Direct Methodology 24

The following companies are the major competitors of Jarvik Heart, Inc.:
CircuLite, Inc.
Rhythm Technologies, Inc.
Sunshine Heart, Inc.
Ventracor Limited
ABIOMED, Inc.
SynCardia Systems, Inc.
World Heart Corporation
Berlin Heart GmbH
MicroMed Technology,Inc.
HeartWare Limited

Customers who bought this item also bought

• Artificial Organs - Global Strategic Business Report
• Organ and Tissue Transplantation - Global Strategic Business Report
• PAREXEL Biopharmaceutical R&D Statistical Sourcebook 2012/2013
• Emerging Market for Clinical Trials in Poland - Cost Advantages of Nearly 30% as Compared to the US
• 23rd European Association for Cardio-Thoracic Surgeons (EACTS) Annual Meeting: Conference Review and Analysis
• Endpoints-Clinical Trials in Orphan Diseases - Highest Number of Terminated Trials Focused on Mulitiple Myeloma
• Clinical Trial Management Systems (CTMS) - Global Strategic Business Report
• Global Glaucoma Drug Pipeline Capsule - 2012
• Healthcare Contract Research Outsourcing Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018
• Patient Recruitment and Retention in Clinical Trials: Emerging Strategies in Europe, the US and Asia